MoneyWorks4Me

USFDA completes inspection of Ajanta Pharma’s facility at Gujarat

27 Jul 2018 Evaluate

US Food and Drug Administration (USFDA) has completed inspection of Ajanta Pharma’s formulation facility at Dahej in the state of Gujarat from July 23-27, 2018. After the inspection, there were no observations found.

Ajanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic business in US and institution business in Africa.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..